Can a best practice advisory improve anticoagulation prescribing to reduce stroke risk in patients with atrial fibrillation?

Atrial fibrillation (AF) is the most common cardiac rhythm disorder and a risk factor for stroke. Randomized trials have demonstrated that anticoagulation can reduce strokes in AF patients. Yet, widespread underutilization of this therapy continues. To address this practice gap, we designed a study to implement and evaluate the effectiveness of a best practice advisory (BPA) for an Atrial Fibrillation Decision Support Tool (AFDST) embedded within our electronic health record. Our intervention is provider-facing, focused on decision support. Clinical setting is ambulatory patients being seen by primary care physicians. We prospectively enrolled 608 patients in our health system who are currently receiving less than optimal anticoagulation therapy as determined by the AFDST and randomized them to one of two arms – 1) usual care, in which the AFDST is available for use; or 2) addition of a BPA to the AFDST notifying clinicians that their patient stands to gain significant benefit from a change in current therapy. Primary outcome was effectiveness of the BPA measured by change to “appropriate thromboprophylaxis” based on the AFDST recommendation at 3 months post-enrollment. Secondary endpoints included Reach and Adoption from the RE-AIM (Reach, Effectiveness, Adoption, Implementation, & Maintenance) framework for implementation studies. Among 562 patients with a minimum follow-up of 3 months, addition of a BPA to the AFDST resulted in significant improvement in anticoagulation therapy, 5 % (12/248) versus 11 % (33/314) p = 0.02, odds ratio 2.31 (95 % CI, 1.17–4.87). A BPA added to an AF decision support tool improved anticoagulation therapy among AF patients in a primary care academic health system setting. [Display omitted] •Anticoagulation reduces strokes in atrial fibrillation (AF) patients, yet widespread underutilization continues.•We evaluated the effectiveness of a best practice advisory (BPA) for an AF decision support tool.•Among 562 patients with non-optimal therapy, we measured change to appropriate anticoagulation.•Addition of a BPA resulted in significant improvement in anticoagulation therapy.